Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure

Circulation

Volumn 104, Issue 12, 2001, Pages 1430-1435

  Nagaya, Noritoshi ^a   Uematsu, Masaaki ^b   Kojima, Masayasu ^a   Ikeda, Yoshihiko ^a   Yoshihara, Fumiki ^a   Shimizu, Wataru ^a   Hosoda, Hiroshi ^a   Hirota, Yuki ^c   Ishida, Hideyuki ^c   Mori, Hidezo ^a   Kangawa, Kenji ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c TOKAI UNIVERSITY   (Japan)

Author keywords

Growth substances; Heart failure; Hormones; Nutrition

Indexed keywords

GHRELIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PLACEBO; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CACHEXIA; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART CONTRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HEMODYNAMICS; HISTOPATHOLOGY; INOTROPISM; LEFT CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WEIGHT GAIN;

EID: 0035908954     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc3601.095575     Document Type: Article

References (27)

1. Idiopathic dilated cardiomyopathy
2. The pathogenesis of cardiac cachexia
3. Body composition, bone metabolism, heart structure and function in growth hormone deficient adults before and after growth hormone replacement therapy at low doses
4. Stimulation of cardiac protein synthesis by insulin-like growth factors
5. Growth hormone improves cardiac performance in experimental heart failure
6. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat: A combined in vivo and in vitro evaluation
7. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy
8. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy
9. A placebo-controlled study of growth hormone in patients with congestive heart failure
10. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance in cardiac cachexia
11. Deficient insulin-like growth factor 1 in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation
12. Ghrelin is a growth-hormone-releasing acylated peptide from stomach
13. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers
14. Growth hormone-independent cardioprotective effects of hexarelin in the rat
15. A role for ghrelin in the central regulation of feeding
16. Ghrelin induces adiposity in rodents
17. Cardiac adrenomedullin gene expression and peptide accumulation after acute myocardial infarction in rats
18. Comparison of echocardiographic methods for assessment of LV shortening and wall stress
19. Hypertrophy, fibrosis and diastolic dysfunction in early canine experimental hypertension
20. Molecular mechanism of growth hormone (GH) deficiency in the spontaneous dwarf rat: Detection of abnormal splicing of GH messenger ribonucleic acid by the polymerase chain reaction
21. 2+ waves in isolated cardiac myocytes
22. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency: A double-blind, placebo-controlled study
23. Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure
24. Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction
25. Cardiac cachexia: A syndrome with impaired survival and immune and neuroendocrine activation
26. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
27. Wasting as independent risk factor for mortality in chronic heart failure